Scalable, systematic and automated process captures and monitors metrics based on patients' treatment priorities for managing Alzheimer's disease and related dementias...
New molecule demonstrates efficacy in a challenging SCI modelExpanding pipeline into new indications of ischemic stroke and ALSVancouver, British Columbia--(Newsfile...
SUNRISE-PD to evaluate the effect of bezisterim (NE3107) on motor and non-motor symptoms in ~60 patients with Parkinson’s disease who...
OCREVUS subcutaneous (SC) injection offers a new, 10-minute administration of OCREVUS with comparable efficacy and safety to intravenous infusion (IV)...
Move highlights division's growth; brings on noted industry experts Matt High and Elijah MarentetteTARRYTOWN, NY / ACCESSWIRE / June 25,...
PrecisionDirect allows auto carriers to improve payment accuracy for provider services SAN DIEGO, June 20, 2024 /PRNewswire/ -- During claims settlements...
Gap in non-oral prescriptions relative to AHS guidelines represents an opportunity to increase awareness of Tonix’s two FDA-approved non-oral treatments...
Single Infusion of ANX005 Demonstrated Significant Improvements Across Multiple Functional and Prognostic Measures That Expedited Recovery in GBS Patients ANX005...
In Study 502, lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key...
Durable improvements across consistent clinical domains in both adult and pediatric patients, including motor skills, communication/socialization, autonomic function, seizures, and...
Available to members in need of care themselves or when supporting others, Guardian becomes the first insurance carrier to include...
MIAMI, FL, June 10, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
MUNICH, June 6, 2024 /PRNewswire/ -- According to the World Health Organization (WHO), at least 80 million people (or 1%...
Augmental Expanding its Early Access Program Beginning Today, Adding New Head-Tracking Feature SAN FRANCISCO, June 6, 2024 /PRNewswire/ -- MIT...
Analysis of a randomized, placebo-controlled study of 1,000+ participants indicates socio-demographics are not a factor impacting clinically meaningful reductions in...
Financing led by Zimmer Biomet with participation from existing investors Johnson & Johnson Innovation – JJDC, Inc., Gideon Strategic Partners,...
VA Health Chat is now available to Veterans in all 18 VISNs across the U.S.DENVER, June 05, 2024 (GLOBE NEWSWIRE)...
Intelligent prior authorization enables faster access to care and higher quality outcomes for members while enhancing provider experience and improving...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation...
NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced presentations highlighting study designs for...